The role of the analytical developer has always been challenging but, in recent years, with the advent of ever-higher expectations, more complex products, regulatory authority and corporate driven innovations there has been an increased need for improved techniques. There are, of course, many ways to tackle some, if not all of these issues, with many solutions such as multimodal and multipurpose technologies arising in the last few years. This meeting will cover these newer procedures and innovations that are being developed and introduced to analytical development and will evaluate their applicability and potential impact to the pharmaceutical and biotechnology industry